Objective To investigate neurodegenerative and inflammatory biomarkers in people with
amyotrophic lateral sclerosis (PALS), evaluate their predictive value for ALS progression …

Background Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting
upper and lower motor neurons in the CNS and leading to paralysis and death. There are …

Objective To investigate inflammatory cytokines in patients with motor neuron disease
(MND) evaluating the putative contribution of amyotrophic lateral sclerosis (ALS)-causing …

Amyotrophic lateral sclerosis (ALS) is an incurable and rapidly progressive neurological
disorder. Biomarkers are critical to understanding disease causation, monitoring disease …

Background Amyotrophic lateral sclerosis (ALS) is a fatal progressive motor neuron disease,
for which there are still no diagnostic/prognostic test and therapy. Specific molecular …

Importance Various factors have been proposed as possible candidates associated with the
prognosis of amyotrophic lateral sclerosis (ALS); however, there is still no consensus on …

As potential treatments for C9ORF72‐associated amyotrophic lateral sclerosis (c9ALS)
approach clinical trials, the identification of prognostic biomarkers for c9ALS becomes a …

Objective Amyotrophic lateral sclerosis (ALS) is the most common adult motor neuron
disease leading to muscular paralysis and death within 3–5 years from onset. Currently …

Amyotrophic lateral sclerosis (ALS) is a multifactorial, multisystem pro-inflammatory
neuromuscular disorder compromising muscle function resulting in death …

Introduction/Aims ALS is a heterogeneous disease that may be complicated or in part driven
by inflammation. NP001, a regulator of macrophage activation, was associated with slowing …